Canada’s trusted source for timely news and information on biosimilar biologics
Canada’s trusted source for timely news and information on biosimilar biologics
Biosimilars are having an increasing role to play in the Canadian health system. How can you stay informed and involved?
- Provide your comments and questions to Arthritis Consumer Experts at feedback@jointhealth.org
- Continue to share perspectives and experiences around this important medication treatment topic
- Help educate your community – they will be affected by the arrival of biosimilars
- Understand how biosimilars are assessed and listed on public and private drug plans
- Take the MOOC online course: developed by leading researchers and clinicians across Canada, this course will enhance knowledge and skills for patients who are using, or beginning to use, a biosimilar.
Ask your health care professional or patient support program about these important questions:
- What are the experts saying about biosimilars?
- Will a biosimilar work for me?
- What is the nocebo effect?
- What clinical evidence supports the safety and efficacy of switching from an originator biologic to its biosimilar version
- What are features of the biosimilar's patient support program?
Stay Informed
Subscribe to Arthritis Consumer Experts’ JointHealthTM newsletters to keep up with the latest news and background analysis about biosimilars.
Arthritis Consumer Experts
© 2024
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.
Arthritis Consumer Experts
© 2000-2021
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.
Arthritis Consumer Experts
© 2000-2021
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.